Top Consumer Driven Health Care Stories
Boehringer Ingelheim sued for allegedly using expired patents to control inhaler market
By Emily CousinsBoehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the FDA's Orange Book, was hit with an class action lawsuit, alleging that the company is using expired patents.










